To clarify how specific the methylation changes detected are in dementia, we examined the methylation levels of APOE and CLU in blood samples of control, AD, dementia with Lewy bodies (DLB), vascular dementia (VaD), and frontotemporal dementia (FTD). This evidence concerns the gene APOE and dementia.